Compounds > levonorgestrel
Page last updated: 2024-08-21

levonorgestrel and Pseudotumor Cerebri

levonorgestrel has been researched along with Pseudotumor Cerebri in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cornblath, WT; De Lott, LB; Khanna, S; Moniz, MH; Musch, DC; Niziol, LM1
Carleton, B; Etminan, M; Kezouh, A; Khosrow-Khavar, F; Magee, LA; Sheldon, C; Sodhi, M; Tremlett, H1
Sivin, I1
Alder, JB; Edwards, R; Fraunfelder, FT1
Green, L; Wysowski, DK1

Other Studies

5 other study(ies) available for levonorgestrel and Pseudotumor Cerebri

ArticleYear
Levonorgestrel intrauterine device use and incident idiopathic intracranial hypertension among commercially insured women.
    Contraception, 2023, Volume: 125

    Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Pseudotumor Cerebri; Retrospective Studies

2023
Pseudotumor cerebri syndrome with different types of hormonal contraceptives in women of child-bearing age.
    European journal of neurology, 2020, Volume: 27, Issue:12

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Middle Aged; Pseudotumor Cerebri; Retrospective Studies; Young Adult

2020
Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Obstetrics and gynecology, 1995, Volume: 86, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Cerebrovascular Disorders; Drug Implants; Female; Humans; Incidence; Levonorgestrel; Pseudotumor Cerebri; Risk Factors; United States; United States Food and Drug Administration

1995
Levonorgestrel implants and intracranial hypertension.
    The New England journal of medicine, 1995, Jun-22, Volume: 332, Issue:25

    Topics: Adolescent; Adult; Drug Implants; Female; Humans; Levonorgestrel; Pseudotumor Cerebri

1995
Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Obstetrics and gynecology, 1995, Volume: 85, Issue:4

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Cerebrovascular Disorders; Combined Modality Therapy; Debridement; Drainage; Drug Implants; Female; Hospitalization; Humans; Levonorgestrel; Plasmapheresis; Pseudotumor Cerebri; Purpura, Thrombotic Thrombocytopenic; Surgical Wound Infection; United States; United States Food and Drug Administration

1995